← FDA DRUG APPROVALS

FDA ANDA · ANDA206801

PALONOSETRON

Sponsor: FRESENIUS KABI USA

APPLICATION
ANDA206801
TYPE
ANDA
ORIGINAL APPROVAL
2018-09-19
LATEST ACTION
2018-09-19
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

PALONOSETRON HYDROCHLORIDEPrescription
PALONOSETRON HYDROCHLORIDE EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) · INJECTABLE · INTRAVENOUS

Approval history

2018-09-19UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →